Context Therapeutics is trading 5.02% lower at $0.30 on October 8, 2026, alongside biotech-sector weakness and broader market pressure; no company-specific catalyst is confirmed.
- XBI was down 2.04% during the regular session.
- No company-specific announcement dated October 8 appears in the company’s press-release listing; its latest listed release is from September 9.
- Live trading volume was not provided.